Your Messages Inbox
Your Article Summary
See Latest ArticlesTeva Announces Approval and Launch of Generic Topamax Tablets
Teva Pharmaceutical Industries, 03/30/09
Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application to market its generic version for Ortho-McNeil's anticonvulsant Topamax Tablets, 25 mg, 50 mg, 100 mg and 200 mg. Shipment of this product has commenced.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Recombinant Human Erythropoietin, Epogin Injection
Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09
Synthon announces European approvals for Raloxifene
Synthon, 12/08/09
US FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania
AstraZeneca, 12/07/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Genentech, 12/08/09
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Article Search
Sponsor